Neoadjuvant Therapy in Melanoma

Opinion
Video

Medical oncologists provide comprehensive insights on neoadjuvant therapy options for patients with melanoma.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
A third of patients had a response [to lifileucel], and of the patients who have a response, half of them were alive at the 4-year follow-up.
We are seeing that, in those patients who have relapsed/refractory melanoma with survival measured as a few weeks and no effective treatments, about a third of these patients will have a response.